Dermagraft-TC data

The La Jolla, Calif., company reported on seven patients in a pilot trial that will enroll up to 10 patients, saying the engineered human dermal tissue combined with a synthetic dermal layer has adhered consistently to wound beds.

In the five patients for which comparisons could be generated so far, the take rate of the graft was equivalent to or better than the control sites, ATIS reported at the American Association of Tissue Banks meeting in San Francisco. ...